Source: Health Canada shortage reports · Updated Oct 27, 2026
Some Glyburide products are in shortage in Canada (1 of 10 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
A sulfonylurea used to lower blood sugar in type 2 diabetes.
Products affected
1 / 10
In shortage since
May 25, 2026
Reports on file
20
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
GLYBURIDE
5MG · TABLET · SANIS HEALTH INC
DIN 02350467 · since May 25, 2026, no end estimate · Disruption of the manufacture of the drug.
Discontinued
TEVA-GLYBURIDE
2.5MG · TABLET · TEVA CANADA LIMITED
DIN 01913670
Resolved
TEVA-GLYBURIDE
2.5MG · TABLET · TEVA CANADA LIMITED
DIN 01913670 · ended Feb 28, 2024 · Disruption of the manufacture of the drug.
Discontinued
GLYBURIDE
2.5MG · TABLET · PRO DOC LIMITEE
DIN 01959352
Discontinued
GLYBURIDE
5MG · TABLET · PRO DOC LIMITEE
DIN 02485664
Discontinued
PMS-GLYBURIDE
5MG · TABLET · PHARMASCIENCE INC
DIN 02236734
Resolved
APO GLYBURIDE TAB 2.5MG
2.5MG · TABLET · APOTEX INC
DIN 01913654 · ended Oct 2, 2020 · Disruption of the manufacture of the drug.
Discontinued
DIABETA
5MG · TABLET · SANOFI-AVENTIS CANADA INC
DIN 02224569
Discontinued
DIABETA
2.5MG · TABLET · SANOFI-AVENTIS CANADA INC
DIN 02224550
Resolved
PMS-GLYBURIDE
5MG · TABLET · PHARMASCIENCE INC
DIN 02236734 · ended Jun 9, 2020 · Product to be discontinued.
Resolved
PMS-GLYBURIDE
5MG · TABLET · PHARMASCIENCE INC
DIN 02236734 · ended Jun 9, 2020 · Product in discontinuation process
Resolved
APO GLYBURIDE TAB 2.5MG
2.5MG · TABLET · APOTEX INC
DIN 01913654 · ended Dec 3, 2019 · Disruption of the manufacture of the drug.
Showing 12 of 20 reports. All reports are on file with Health Canada.
What's happening
Glyburide is currently affected by an active shortage report filed with Health Canada by SANIS HEALTH INC.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Glyburide is classified under “BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS” (ATC A10BB).
Recent changes
Oct 27, 2026
Status changed
Common questions
What is Glyburide used for?
A sulfonylurea used to lower blood sugar in type 2 diabetes.
When will Glyburide be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Glyburide in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.